7th Asia Pacific Gastroenterology Cancer Summit 2019

APGCS 2020 is Going Virtual

Reserve your Seats Now

Join us for a virtual experience to interact with GI Cancers' global key opinion leaders

CME applied with European Accreditation Council for Continuing Medical Education

CME applied with Singapore Medical Council

VIRTUAL CONFERENCE

Live Agenda Session Video Streaming
Live stream conference sessions, networking and interaction
Allow remote Attendees to participate in Live Polling
Questions can be asked live from anywhere
Easily cycle between sessions, video, comments and Q&A

NETWORKING

Virtual Face to Face Meetings
Connect with onsite and offsite participants
Offsite participants provided with a virtual meeting automatically
In-App live video calling
Make notes and download post meeting alerts are partnered with custom emails and push notifications

DESKTOP/LAPTOP ACCESS

All features available via a dedicated web link
Stream live via a laptop or desktop
Login to a native device simultaneously
Full screen mode for streaming to large monitors

Dear Colleagues and Friends,

With each year APGCS is building a strong educational and networking platform in the Asia Pacific region where we witness strong presentations, lively debates, insightful data and engaging panel discussions covering the latest in GI Cancer Care.

Over the years we have designed the program to present an engaging platform to critically examine evidence-based strategies as well as contemporary best practices and clinical decision-making to reach our common objective of improving patient care.

We would like to thank the Singapore Society of Oncology for their continuous support and members of National Cancer Center Singapore, National University Hospital for their contribution & participation.

APGCS 2020 will once again assemble key opinion leaders from Asia and across the world for this two-day meeting. Hepatobiliary cancer and gastric cancer in particular are often regarded as Asian cancers and we are privileged that the leading lights in these cancers will be on our faculty.